Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stellora.AI (formerly LunaPro.AI) is an EU-based deep-tech company specializing in agentic intelligent infrastructure and quantum-accelerated AI for high-stakes industries, with a primary focus on healthcare and Quantum-Bio research. The company's flagship platform, Quantum Flow, utilizes a proprietary multilayer retrieval-augmented generation (RAG) engine and a swarm of specialized AI agents to translate complex scientific data into functional quantum code for live hardware and simulators. By automating the creation of quantum circuits directly from scientific inputs, Stellora.AI aims to bridge the computational gap in modern science and accelerate drug discovery for challenging conditions such as drug-resistant epilepsy and cancer. Headquartered in Prague, Czech Republic, the company is a founding member of the AI.ForHumanity.Global consortium, promoting ethical, data-sovereign, and accuracy-first AI solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stellora.AI.